Bioatla Inc (BCAB)

Jul 24, 2025

What analysts say about BioAtla Inc. stockConsistently high returns - Autocar Professional

Jul 24, 2025

Jul 22, 2025

What drives BioAtla Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

BioAtla Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Now The Time To Buy BioAtla Inc (NASDAQ: BCAB) Stock? - Stocksregister

Jul 22, 2025

Jul 22, 2025

Is BioAtla Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is BioAtla Inc. stock a good hedge against inflationFree Consultation - Newser

Jul 22, 2025

Jul 19, 2025

What analysts say about BioAtla Inc. stock outlookFast Gains With Reduced Risk - beatles.ru

Jul 19, 2025

Jul 17, 2025

BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting - The Manila Times

Jul 17, 2025

Jul 15, 2025

What makes BioAtla Inc. stock price move sharplyTrending Stock Alert - Newser

Jul 15, 2025

Jul 15, 2025

Why BioAtla Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 15, 2025

Jul 15, 2025

How BioAtla Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025

Jul 08, 2025

BioAtla (NASDAQ:BCAB) Stock Price Up 2.6% – Here’s Why - Defense World

Jul 08, 2025

Jul 04, 2025

BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma - Yahoo Finance

Jul 04, 2025

Jun 20, 2025

BioAtla Approves 2025 Corporate Bonus Plan - TipRanks

Jun 20, 2025

Jun 14, 2025

BioAtla, Inc. (NASDAQ:BCAB) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025

Jun 09, 2025

Jane Street Group LLC Purchases 100,204 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 09, 2025

Jun 09, 2025

BioAtla, Inc. (NASDAQ:BCAB) Stock Position Lowered by Two Sigma Advisers LP - Defense World

Jun 09, 2025

Jun 08, 2025

Millennium Management LLC Cuts Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 08, 2025

Jun 07, 2025

BioAtla (NASDAQ:BCAB) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jun 07, 2025

Jun 06, 2025

BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025 - MSN

Jun 06, 2025

Jun 03, 2025

Why Did BioAtla Inc (NASDAQ: BCAB) Drop So Much? - Stocksregister

Jun 03, 2025

Jun 03, 2025

BioAtla reports promising trial results for cancer drug By Investing.com - Investing.com South Africa

Jun 03, 2025

Jun 02, 2025

BioAtla reports promising trial results for cancer drug - Investing.com

Jun 02, 2025

Jun 02, 2025

BioAtla (BCAB) Showcases Promising Data for Ozuriftamab Vedotin in Key Cancer Trial | BCAB Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen - The Manila Times

Jun 02, 2025

Jun 02, 2025

BioAtla's New Cancer Drug Achieves 13x Better Response Rate Than Standard Treatment in Phase 2 Trial - Stock Titan

Jun 02, 2025